vs
Side-by-side financial comparison of LANDMARK BANCORP INC (LARK) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
LANDMARK BANCORP INC is the larger business by last-quarter revenue ($18.8M vs $12.6M, roughly 1.5× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 27.0%, a 223.7% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 14.0%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 13.1%).
Landmark Bancorp Inc is a U.S.-based bank holding company operating Landmark National Bank, primarily serving communities across Kansas. It provides a full range of personal and commercial banking services including deposit accounts, residential mortgages, commercial loans, and wealth management solutions, catering to individual consumers, small businesses and local mid-sized enterprises.
LARK vs SPRO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.8M | $12.6M |
| Net Profit | $5.1M | $31.5M |
| Gross Margin | — | — |
| Operating Margin | — | — |
| Net Margin | 27.0% | 250.7% |
| Revenue YoY | 14.0% | 24080.8% |
| Net Profit YoY | 7.8% | 250.9% |
| EPS (diluted) | — | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $18.8M | — | ||
| Q4 25 | $18.7M | $12.6M | ||
| Q3 25 | $18.2M | $0 | ||
| Q2 25 | $17.3M | $0 | ||
| Q1 25 | $16.5M | $12.0K | ||
| Q4 24 | $15.8M | $52.0K | ||
| Q3 24 | $15.9M | $65.0K | ||
| Q2 24 | $14.7M | $114.0K |
| Q1 26 | $5.1M | — | ||
| Q4 25 | $4.7M | $31.5M | ||
| Q3 25 | $4.9M | $-7.4M | ||
| Q2 25 | $4.4M | $-1.7M | ||
| Q1 25 | $4.7M | $-13.9M | ||
| Q4 24 | $3.3M | — | ||
| Q3 24 | $3.9M | $-17.1M | ||
| Q2 24 | $3.0M | $-17.9M |
| Q1 26 | — | — | ||
| Q4 25 | 31.7% | — | ||
| Q3 25 | 33.4% | — | ||
| Q2 25 | 30.9% | — | ||
| Q1 25 | 34.7% | -122758.3% | ||
| Q4 24 | 15.2% | — | ||
| Q3 24 | 30.3% | -28604.6% | ||
| Q2 24 | 24.5% | -16720.2% |
| Q1 26 | 27.0% | — | ||
| Q4 25 | 32.1% | 250.7% | ||
| Q3 25 | 27.1% | — | ||
| Q2 25 | 25.4% | — | ||
| Q1 25 | 28.5% | -115550.0% | ||
| Q4 24 | 26.5% | — | ||
| Q3 24 | 24.8% | -26380.0% | ||
| Q2 24 | 20.5% | -15668.4% |
| Q1 26 | — | — | ||
| Q4 25 | $0.66 | $0.56 | ||
| Q3 25 | $0.85 | $-0.13 | ||
| Q2 25 | $0.75 | $-0.03 | ||
| Q1 25 | $0.81 | $-0.25 | ||
| Q4 24 | $0.47 | — | ||
| Q3 24 | $0.68 | $-0.32 | ||
| Q2 24 | $0.52 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.9M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $59.0M |
| Total Assets | $1.6B | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $31.9M | — | ||
| Q4 25 | — | $40.3M | ||
| Q3 25 | — | $48.6M | ||
| Q2 25 | — | $31.2M | ||
| Q1 25 | — | $48.9M | ||
| Q4 24 | — | $52.9M | ||
| Q3 24 | — | $76.3M | ||
| Q2 24 | — | $63.5M |
| Q1 26 | — | — | ||
| Q4 25 | $160.6M | $59.0M | ||
| Q3 25 | $155.7M | $26.5M | ||
| Q2 25 | $148.4M | $32.8M | ||
| Q1 25 | $142.7M | $33.8M | ||
| Q4 24 | $136.2M | $46.1M | ||
| Q3 24 | $139.7M | $65.5M | ||
| Q2 24 | $128.3M | $80.5M |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $68.9M | ||
| Q3 25 | $1.6B | $54.2M | ||
| Q2 25 | $1.6B | $62.1M | ||
| Q1 25 | $1.6B | $77.7M | ||
| Q4 24 | $1.6B | $110.5M | ||
| Q3 24 | $1.6B | $135.2M | ||
| Q2 24 | $1.6B | $149.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-8.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $21.6M | $-8.4M | ||
| Q3 25 | $10.3M | $17.4M | ||
| Q2 25 | $439.0K | $-17.7M | ||
| Q1 25 | $8.0M | $-4.0M | ||
| Q4 24 | $14.2M | $-23.4M | ||
| Q3 24 | $8.1M | $12.8M | ||
| Q2 24 | $4.4M | $-18.7M |
| Q1 26 | — | — | ||
| Q4 25 | $21.0M | — | ||
| Q3 25 | $10.1M | — | ||
| Q2 25 | $354.0K | — | ||
| Q1 25 | $8.0M | — | ||
| Q4 24 | $11.9M | — | ||
| Q3 24 | $7.8M | — | ||
| Q2 24 | $3.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | 112.5% | — | ||
| Q3 25 | 55.4% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | 75.6% | — | ||
| Q3 24 | 49.3% | — | ||
| Q2 24 | 25.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.2% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 14.7% | — | ||
| Q3 24 | 1.8% | — | ||
| Q2 24 | 4.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 4.56× | -0.26× | ||
| Q3 25 | 2.09× | — | ||
| Q2 25 | 0.10× | — | ||
| Q1 25 | 1.71× | — | ||
| Q4 24 | 4.34× | — | ||
| Q3 24 | 2.06× | — | ||
| Q2 24 | 1.45× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
